Biotechnology Stocks II: Compare Returns of S&P 500 to Mineralys Therapeutics, Inc. (MLYS)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and MLYS | ||
|---|---|---|
| S&P 500 | MLYS | |
| Start Date | Mar-01-2023 | Mar-31-2023 |
| Start Price | $2,800.75 | $15.66 |
| End Date | May-01-2025 | May-21-2025 |
| End Price | $5,604.14 | $16.66 |
| Number Monthly Prices | 27 | 27 |
| Min Date | Mar-01-2023 | Nov-30-2023 |
| Min Price | $4,146.44 | $6.66 |
| Max Date | Dec-01-2024 | Jun-30-2023 |
| Max Price | $6,010.09 | $17.05 |
| Total Return | 35.16% | 6.39% |
| Annualized Return | 14.33% | 2.79% |
| Current Value of $1,000 Purchase | $1,352 | $1,064 |
| Number Returns | 351 | 351 |
| Average Return | 14.99% | 7.11% |
| Minimum Return | -6.75% | -60.94% |
| Maximum Return | 44.95% | 150.15% |
| Number Profitable Returns | 322 | 169 |
| Percent Profitable Returns | 91.74% | 48.15% |
| Number Unprofitable Returns | 29 | 182 |
| Percent Unprofitable Returns | 8.26% | 51.85% |
| Profitable to Unprofitable Returns Ratio | 11.10 | 0.93 |
MLYS Performance Table and Chart
MLYS Dollar-cost Average
MLYS Trendline Chart
MLYS Moving Average Chart
MLYS Stock Return Map - See Patterns of Gains and Losses
MLYS Stock Returns/Purchase Dates